{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05029752",
            "orgStudyIdInfo": {
                "id": "2020-1309"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2021-09419",
                    "type": "OTHER",
                    "domain": "NCI-CTRP Clinical Trials Process Registry"
                }
            ],
            "organization": {
                "fullName": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "Feasibility of Digital Thermal Monitoring to Assess Endothelium-Dependent Vasodilation in Patients Undergoing Hematopoietic Cell Transplantation (HCT)",
            "officialTitle": "Feasibility of Digital Thermal Monitoring to Assess Endothelium-Dependent Vasodilation in Patients Undergoing Hematopoietic Cell Transplantation (HCT)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "feasibility-of-digital-thermal-monitoring-to-assess-endothelium-dependent-vasodilation-in-patients-undergoing-hematopoietic-cell-transplantation-hct"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2021-06-30",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-08-25",
            "studyFirstSubmitQcDate": "2021-08-30",
            "studyFirstPostDateStruct": {
                "date": "2021-09-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "The Vendys II, an FDA-approved device, uses finger digital thermal monitoring (DTM) after a period of blood flow restriction to evaluate vascular health. This study will evaluate the feasibility of using this device to measure the Vascular Reactivity Index (VRI) in children and adolescents/young adults (AYA) undergoing hematopoietic cell transplantation (HCT).",
            "detailedDescription": "Primary Objective:\n\n-Assess the feasibility of the use of VENDYS-II in children and AYA as a measure of vascular endothelial function, where feasibility is defined as completion of the evaluation by at least 70% of consented participants.\n\nSecondary Objective:\n\n-Summarize the incidence of any adverse events that precludes completion of assessment of endothelium-dependent vasodilation using the Vendys II in children and AYA."
        },
        "conditionsModule": {
            "conditions": [
                "Vascular",
                "Endothelial",
                "Endothelial Dysfunction",
                "Endothelix"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Vendys II Device",
                    "type": "OTHER",
                    "description": "Your participation in this study will be over after your blood vessel health is measured 1 time with the Vendys II device",
                    "interventionNames": [
                        "Device: Vendys II Device"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Vendys II Device",
                    "description": "Using the device",
                    "armGroupLabels": [
                        "Vendys II Device"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "The use of VENDYS-II in children and AYA as a measure of vascular endothelial function.",
                    "timeFrame": "through study completion, an average of 1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria for HCT candidates:\n\n* Children, adolescents and young adults (AYA) 6-26 years of age who are HCT candidates\n* Recipients within 30 days prior to or within 14 days after autologous and allogeneic HCT.\n\n  -. Any preparative regimen.\n* Willing and eligible to enroll on PA19-0756\n\nInclusion Criteria for Healthy Donors:\n\n- Healthy HCT donors between the ages of 6-26 years of age.\n\nExclusion Criteria:\n\n* Any subject who does not consent/assent to participation.\n\n  -. Any subject with an injury or deformation to the index finger which prevents proper fit of the device.\n* Any subject with skin toxicity or neuropathy which prevents comfortable use of the device.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "6 Years",
            "maximumAge": "26 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Dristhi Ragoonanan",
                    "role": "CONTACT",
                    "phone": "(713) 792-6620",
                    "email": "dragoonanan@mdanderson.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Dristhi Ragoonanan",
                    "affiliation": "M.D. Anderson Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "M D Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dristhi Ragoonanan",
                            "role": "CONTACT",
                            "phone": "713-792-6620",
                            "email": "dragoonanan@mdanderson.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "M D Anderson Cancer Center",
                    "url": "http://www.mdanderson.org"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}